Triple antithrombotic therapy with aspirin, clopidogrel and warfarin--a persisting dilemma.
Zimarino
M
M
Institute of Cardiology and Center of Excellence on Aging, G. d 'Annunzio University, Chieti, Italy. m.zimarino@unich.it
Renda
G
G
De Caterina
R
R
D001241:Aspirin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy; D000077144:Clopidogrel; D003328:Coronary Thrombosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D014859:Warfarin; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin